and clinical trials play a vital role in the Lankenau
Heart Institute’s efforts to prevent, diagnose and treat the full
range of heart conditions. These trials often lead the way for new and
promising treatments for patients with heart disease.
Directed by internationally renowned physician and researcher William
A. Gray, MD, System Chief, Division of Cardiovascular Disease, the Lankenau
Institute for Medical Research’s (LIMR) Center for Clinical
Cardiology is a recognized leader in innovative clinical cardiology and
cardiac surgery research. Its focus includes arrhythmias,
atherosclerosis, heart failure, peripheral vascular disease, preventive
medicine and cardiac surgery with an emphasis on valve disease.
World-class scientist and heart rhythm expert Charles
Antzelevitch, PhD, joined LIMR as Executive Director of
Cardiovascular Research in 2015. Dr. Antzelevitch is spearheading
efforts to develop new treatments for abnormal and potentially deadly
heart rhythms. Dr. Antzelevitch is collaborating with Lankenau Heart
Institute physicians on translational and clinical cardiac research.
for Clinical Cardiology also provides support for LIMR’s program in
cardiovascular research, which focuses on the development of novel drugs
and devices in the areas of arrhythmia disorders, heart attacks and
strokes, and heart failure. Patient outcomes, the causes of high blood
pressure and the use of stem cells in cardiac regeneration are also
Learn more about the clinical trials currently being offered by our
renowned cardiologists and heart surgeons at the Lankenau Heart
For more information, call 1.866.CALL.MLH.